Fluent

Fluent Debt/EBITDA

Delisted

The Total Debt to EBITDA Ratio of Fluent (TIUM.U.CN) as of Nov 5, 2026 is 3.25. In the previous year, Total Debt to EBITDA Ratio was 4.87 — a change of -33.33% (lower).

Debt/EBITDA

3.25

YoY

-33.33%

Last updated:

Total Debt to EBITDA Ratio of Fluent is 2023 3.25 . Total Debt to EBITDA Ratio of Fluent was 2022 4.87 . It decreases by -33.33% lower compared to the previous year.

The Fluent Debt/EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt/EBITDA
Date
Debt/EBITDA
Jan 1, 2019
-1.94 USD
Jan 1, 2020
-3.77 USD
Jan 1, 2021
-8.55 USD
Jan 1, 2022
4.87 USD
Jan 1, 2023
3.25 USD
The Fluent Debt/EBITDA history
YEARDebt/EBITDAYoY
3.25-33.33%
4.87-156.95%
-8.55+126.76%
-3.77+94.77%
-1.94—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Fluent Stock analysis

What does Fluent do? Fluent Corp operates under the private label Fluent, selling medical cannabis products in Florida, Texas, and Pennsylvania. The company's products include oral drops, capsules, suppositories, topicals, syringes, dried flower, pre-rolls, cartridges, edibles, and accessories. Subsidiaries such as Cansortium Holdings LLC and Cansortium Florida, LLC handle production and sales, while Fluent Servicing, LLC manages servicing aspects. The company's revenue comes from direct sales of medical cannabis products through its licensed operations in multiple states. Fluent Corp's target customers are patients seeking medical cannabis treatments, with products tailored to various consumption methods. The company leverages its subsidiaries to maintain compliance and expand its market reach across different states. Sales are conducted through licensed dispensaries and medical cannabis programs, focusing on the healthcare segment of the cannabis industry. The business model relies on the production and sale of medical cannabis under the private label Fluent, utilizing subsidiaries to manage state-specific operations. Products are distributed through established medical cannabis channels, with no mention of additional revenue streams beyond product sales. The company's focus remains on the medical cannabis market, serving patients in Florida, Texas, and Pennsylvania. Fluent is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Fluent stock

Total Debt to EBITDA Ratio of Fluent is 3.25 in 2023.

Total Debt to EBITDA Ratio of Fluent changed from 4.87 to 3.25, representing a -33.33% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Total Debt to EBITDA Ratio Fluent since 2006 – with annual values, charts, and detailed analysis.

Debt/EBITDA measures total debt relative to earnings before interest, taxes, depreciation, and amortization. It indicates the years needed to repay all debt from EBITDA.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Total Debt to EBITDA Ratio's Fluent with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Fluent

All Key Metrics — Fluent